SFDA bans cosmetic products packaged as syringes, ampoules, and vials

The Saudi Food and Drug Authority (SFDA) has announced a new regulatory directive aimed at curbing the use of pharmaceutical-style packaging for cosmetic products. According to the Saudi Gazette, the authority has officially banned the circulation of cosmetic items intended for external use that are presented in formats resembling medical supplies, such as ampoules, vials, and syringes. This policy is set to take full effect on January 1, 2027.

In a circular distributed to manufacturers and importers, the SFDA noted that it had observed an increase in cosmetic products being marketed in packaging that mimics clinical or pharmaceutical forms. The authority expressed concern that such presentation could lead to consumer confusion regarding the nature and intended use of the products. To address these safety and clarity concerns, the new regulations mandate strict compliance for any products currently utilizing these formats.

Under the new guidelines, the circulation of cosmetic products in the form of syringes is strictly prohibited. For products sold in ampoules or vials, manufacturers are now required to print clear, legible warnings in both Arabic and English on both the inner and outer packaging. These labels must explicitly state that the item is a cosmetic product for external use only and include a clear instruction that the product is not for injection. This move reflects the SFDA's ongoing efforts to standardize product safety and ensure that consumers can easily distinguish between medical treatments and cosmetic applications.